Oncimmune Holdings plc (LON:ONC – Get Rating) shares dropped 0.6% on Friday . The stock traded as low as GBX 84 ($1.01) and last traded at GBX 85 ($1.02). Approximately 23,648 shares traded hands during trading, a decline of 56% from the average daily volume of 54,092 shares. The stock had previously closed at GBX 85.50 ($1.03).
Oncimmune Stock Down 0.6 %
The company has a market capitalization of £59.05 million and a PE ratio of -8.33. The company’s 50 day moving average is GBX 89.21 and its two-hundred day moving average is GBX 117.40. The company has a quick ratio of 1.04, a current ratio of 1.08 and a debt-to-equity ratio of 677.62.
Oncimmune Holdings plc develops and commercializes technologies that enable cancer diagnosis in the United Kingdom, North America, Europe, and internationally. It offers EarlyCDT-Lung, a immunodiagnostic test for detecting and identifying lung cancer. The company also develops SeroTag, a platform that is used to discover and validate biomarkers for stratifying patients in multiple cancer indications, infectious diseases, and with various autoimmune diseases; and NavigAID, a disease-specific characterization panel.
- MarketBeat: Week in Review 7/25 – 7/29
- Procter’s Earnings Start To Show Weakness In Q4
- The One Question You Have to Ask Before Investing in INTC Stock
- Home Depot: A Beautiful Boring Stock to Navigate a Bear Market
- Could CRISPR Therapeutics be a Moonshot Hiding in Plain Sight?
Receive News & Ratings for Oncimmune Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncimmune and related companies with MarketBeat.com's FREE daily email newsletter.